January 12, 2026 · Form 4 insider transaction
Aubuchon Neil William bought 180,000 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 14 days after the transaction.
25% of the shares subject to the option will vest immediately, and 25% of the shares subject to the option will vest on each one-year anniversary of the grant date over the next three years.